Bgi Genomics Co.,Ltd.’s Net Profit Dropped 47.8% in First Three Quarters of 2022

Bgi Genomics Co.,Ltd. (深圳华大基因股份有限公司) (300676.SZ) reported a net profit of 746.7 million yuan in the first three quarters of 2022, down 47.8% year-on-year.

Meanwhile, the company posted 4.5 billion yuan in revenue, down 12.4% year-on-year.

At the end of the reporting period, it had 13.9 billion yuan in total assets and 3.8 billion yuan in total liabilities, with a liability-to-asset ratio of 27.4%.